Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Notice of Change: Grants Administration Information added for NCI's Participation on PA-27-036, NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)

Active

NOT-CA-26-019Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This Notice of Change, identified by solicitation number NOT-CA-26-019, updates the NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed) under PA-27-036. The primary purpose of this amendment is to incorporate specific Grants Administration Information regarding the National Cancer Institute's participation in the program. The update specifically modifies Section VII, Agency Contacts, to include the Office of Grants Administration for the National Cancer Institute as a financial and grants management contact. No other changes have been made to the original PA-27-036 guidelines. Interested parties can coordinate with the Center for Cancer Training or the Office of Grants Administration for further inquiries.

General Info

Notice NOT-CA-26-019 adds NCI grants administration contacts to NIH program PA-27-036.

Agency

National Institutes Of Health → National Cancer Institute

NAICS

923120 - Administration of Public Health Programs

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedOct 20

Contract opportunity posted

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyNational Institutes Of Health → National Cancer Institute

Contacts2 people available

OfficeUSA

Organization / AgencyNational Institutes Of Health → National Cancer Institute

Office AddressUSA

Contacts

Office of Grants Administration

contact@example.gov

National Cancer Institute (NCICenter for Cancer Training

contact@example.gov

Full Description

Show more

This Notice of Change adds the Grants Administration Information for NCI's Participation on PA-27-036, NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed). In Section VII. Agency Contacts, Financial/Grants Management Contact(s), this information has been added: Office of Grants Administration National Cancer Institute (NCI) There are no other changes to PA-27-036.

Similar Contracts

Same NAICS industry code

Healthcare Preparedness Program

Solicitation # DPRE27HPP

The Healthcare Preparedness Program, solicitation number DPRE27HPP, is a grant opportunity offered by the New Jersey Department of Health to support the sustainment and further development of Healthcare Preparedness Program Healthcare Coalitions. With an estimated total funding amount of 800,000 dollars, the program is open to specific eligible entities, including New Jersey-based acute care facilities, academic medical institutions, accredited institutions of higher education, and non-profit healthcare or public health professional associations with statewide jurisdiction. The award period for this program is scheduled from January 1, 2027, through June 30, 2027. Applicants must follow a strict submission process via the System for Administering Grants Electronically (SAGE) under the program name DPREMS HPP Coalition 2027. Mandatory requirements include creating a SAGE account, submitting a Letter of Interest as specified in the Request for Applications, and attending a required Technical Assistance Call. All final applications must be submitted through SAGE by the deadline of November 13, 2026. Administrative inquiries are directed to Karen Fox in Grants Program Coordination at the New Jersey Department of Health.

NJ Department of Health

POSTED

DEADLINE

County Environmental Health Act Grants (CEHA)

Solicitation # https://dep.nj.gov/grantandloanprograms/county-environmental-health-act-grants-ceha/

The County Environmental Health Act Grants (CEHA) is a state-level funding opportunity provided by the New Jersey Department of Environmental Protection. Falling under the environment category of the New Jersey Grants Management Office, this program is designed to support environmental health initiatives within the state. Applications for this grant are accepted on a rolling basis, meaning there is no fixed closing date for submissions. Interested parties can find full program details and application instructions through the official NJ Department of Environmental Protection website.

NJ Department of Environmental Protection

POSTED

DEADLINE

27EHSCARHTPRURALPARTNERSRFA: Rural Health Transformation Program (RHTP) Rural Partners RFA

Solicitation # BD-27-1039-EHS01-EHS01-134186

The Massachusetts Executive Office of Health and Human Services is soliciting applications for the Rural Health Transformation Program (RHTP), a five-year federal investment totaling 800 million dollars funded by the Centers for Medicare & Medicaid Services. The program aims to strengthen healthcare access, improve population health, and advance long-term well-being across rural Massachusetts. Eligible rural facilities, providers, municipalities, and community organizations can apply for technical assistance, planning support, and direct funding across six key initiatives: Population Health Advancement, Innovation in Rural Care Models, Healthcare Training (THRIVE), Healthy Rural Communities, Technology Interoperability and Connectivity, and Facility Modernization and Re-Use. The initial period of participation runs from October 30, 2026, through September 30, 2027, with future participation subject to new procurement processes in 2027. Funding levels vary by activity, ranging from 75,000 dollars for regional chronic disease planning to 2.5 million dollars for critical capital updates at rural hospitals. Applications must be submitted as a PDF via email to EOHHS-Procurement@mass.gov by 5:00 PM ET on October 26, 2026. Award decisions will be based on the scope of applications, available funding, program priorities, community need, and the funding level required for successful implementation.

POSTED

DEADLINE

Public Health Strategy & Collective Impact ConsultingThis subcontract for Public Health Strategy and Collective Impact Consulting supports the Guilford County Department of Health and Human Services in North Carolina. The primary objective is to provide strategic planning and capacity building for prime contractors, specifically focusing on the implementation of a multi-year collective action framework designed to reduce infant mortality. By utilizing Collective Impact models, the project aims to enhance organizational performance and strengthen the capabilities of public health officials. The selected provider will be responsible for delivering a comprehensive implementation roadmap, detailed capacity building reports, and defined strategic performance milestones. This effort falls under NAICS code 923120 and is managed by the County of Guilford. Interested parties must respond by October 30, 2026.

County of Guilford

POSTED

DEADLINE

Accelerated Implementation of Data Management and Sharing Plan Changes for NIH Career Development (K) Awards

Solicitation # NOT-OD-26-120

The National Institutes of Health has issued notice NOT-OD-26-120 to accelerate the removal of Data Management and Sharing Plan requirements for Career Development (K) Awards. While previously scheduled for October 12, 2027, this change is now effective immediately. The decision stems from the fact that K awards prioritize career development over primary research project support, and removing this requirement is intended to reduce the administrative burden on both applicants and their institutions. Under these updated guidelines, active K award recipients are no longer required to submit or update a DMS Plan, including within the Research Performance Progress Report. This exemption also applies to pending applications currently in the pre-award or Just-in-Time process, as well as all future applications. The NIH has clarified that the absence of a DMS Plan for these specific awards will not be viewed as noncompliant with general data sharing policies.

National Institutes Of Health Office Of The Director

POSTED

DEADLINE

NIH Operates Under a Continuing Resolution

Solicitation # NOT-OD-26-131

The National Institutes of Health is operating under the Continuing Appropriations and Extensions Act, 2027, which extends government operations through December 11, 2026, at the Fiscal Year 2026 enacted level. Under this resolution, the NIH is prohibited from implementing revisions to the Uniform Administrative Requirements for Federal Awards until the expiration date. Additionally, NIH Institutes and Centers maintain the discretion to issue non-competing research grant awards at levels lower than those listed on the most recent Notice of Award, with potential upward adjustments considered only after FY 2027 appropriations are enacted. All legislative mandates and fiscal policies from FY 2026 remain in effect, including the salary limitation set at Executive Level II of the Federal Pay Scale. The Ruth L. Kirschstein National Research Service Award stipend levels and tuition fees also remain consistent with previous notices. Institutions are expected to monitor their expenditures closely during this period to ensure financial stability until new appropriations are finalized.

National Institutes Of Health

POSTED

DEADLINE

Strengthening Collaboration Between Tuberculosis Control Programs and Affiliated Partners in the United States.The Centers for Disease Control and Prevention is offering funding to a single recipient to enhance collaboration and relationships between tuberculosis control programs, TB controllers, and various affiliated partners across the United States. This initiative builds upon previous efforts to strengthen ties with national TB control programs, federal agencies, academic institutions, businesses, and community or faith-based organizations. The primary goal of this effort is to support the CDC Division of Tuberculosis Elimination in its mission to prevent, control, and eventually eliminate tuberculosis to improve overall health and quality of life. This forecast is managed by the Department of Health and Human Services under the National Center for HIV, Viral Hepatitis, Hepatitis B, and STI, with Martha Boisseau serving as the point of contact.

Centers For Disease Control - Nchhstp

POSTED

DEADLINE

Notice of Opportunity to Participate in the Implementation Council for One Care

Solicitation # BD-27-1039-EHS01-ASHWA-133664

The Massachusetts Executive Office of Health and Human Services, through MassHealth, is seeking diverse individuals and representatives from community-based organizations to serve on the Implementation Council for the One Care program. One Care is a coordinated health plan that integrates Medicare and MassHealth benefits for eligible adults aged 21 to 64. The Council's primary purpose is to partner with MassHealth to improve the program by monitoring healthcare access, reviewing member experiences, and advising on strategies to strengthen the delivery of mental health, substance use, and long-term services. Selected members will serve an initial two-year term with the possibility of an extension. The commitment involves attending virtual meetings via Zoom twice per month during regular business hours, with each session lasting approximately two hours. Compensation includes a 75 dollar stipend for each council meeting attended and 25 dollars per hour for approved engagement meetings or activities, such as in-person town halls. Applicants are ineligible if they have a direct or indirect employment or contractual relationship with My Ombudsman or a One Care Plan. Interested candidates must submit a completed application form by November 2, 2026, at 5:00 PM via the Mass.gov website, the COMMBUYS portal, or email. Applications are evaluated by a committee based on clarity and completeness, the applicant's understanding of the council's goals, and their relevant knowledge and experience with the One Care program. Final selections are made by the Assistant Secretary for MassHealth or their designee.

POSTED

DEADLINE

Advancing Global Health

Solicitation # DFOP0017890

The Department of State Bureau of Global Health Security and Diplomacy is soliciting Statements of Interest under Annual Program Statement DFOP0017890 to advance the America First Global Health Strategy. This initiative seeks to save lives, strengthen health systems, and foster self-reliance through projects that complement bilateral Memoranda of Understanding with partner governments. With a total estimated funding pool of up to 4.5 billion dollars, the program anticipates making up to 100 awards ranging from 500,000 dollars to 250 million dollars each, with performance periods extending up to five years. Funding may be delivered via grants, cooperative agreements, or fixed amount awards. The program is implemented through specific Addenda targeting diverse global health priorities. These include large-scale health system transitions and MOU implementations in Nigeria, Uganda, Malawi, Mozambique, Cameroon, and Cote d'Ivoire, as well as thematic initiatives such as the elimination of neglected tropical diseases, accelerating nutrition progress, rapid outbreak response, child protection, and innovations in population-based surveillance. The application process is a two-step sequence beginning with a Statement of Interest. These are evaluated based on the quality of the program idea, organizational capacity, and the ability to achieve objectives. While a Unique Entity Identifier and SAM.gov registration are not required for the initial phase, they are mandatory for any organization moving forward to a full proposal.

Bureau Of Global Health Security And Diplomacy

POSTED

about 1 month ago

DEADLINE

Cancer Prevention and Control Programs for State, Territorial, and Tribal OrganizationsThe Centers for Disease Control and Prevention's Division of Cancer Prevention and Control is seeking eligible state, territorial, and tribal organizations to implement comprehensive cancer surveillance, prevention, and control strategies. The primary objective is to improve health outcomes through a coordinated approach that integrates clinical preventive services and cancer survivorship to reduce the overall cancer burden in targeted communities. Funding is allocated across three national programs. The National Breast and Cervical Cancer Early Detection Program provides screening and diagnostic services for low-income women without adequate insurance, with an optional component for evidence-based interventions. The National Comprehensive Cancer Control Program supports coalition-led efforts to execute jurisdiction-wide cancer plans, while the National Program of Cancer Registries focuses on the implementation of population-based central cancer registry programs.

Centers For Disease Control - Nccdphp

POSTED

about 1 month ago

DEADLINE

Native Public Health ResilienceThe Native Public Health Resilience initiative is a forecast for a new cohort of awards issued by the Indian Health Service under the Department of Health and Human Services. These awards are specifically designed to provide funding to Tribes and Tribal Organizations to support the delivery of Essential Public Health Services. The opportunity is categorized under NAICS code 923120 and was posted on September 10, 2026. Interested parties can coordinate through the Division of Grants Management or access further details via the provided grants.gov link.

Indian Health Service

POSTED

about 1 month ago

DEADLINE

Limited Competition: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)The John Lewis NIMHD Research Endowment Program, administered by the National Institutes of Health under the Department of Health and Human Services, is designed to enhance research infrastructure and training capacity at eligible institutions of higher education to support health disparities research. The program focuses on four strategic objectives: upgrading physical infrastructure and equipment, developing technical expertise, expanding relevant academic science programs, and recruiting high-level researchers for faculty positions. It is important to note that this program provides institutional support and does not directly fund specific research projects. This opportunity is a forecast for a limited competition, meaning only eligible organizations will be invited to apply. Applications will undergo a standard NIH peer-review process, and funding will be awarded based on the merit of the proposal. Clinical trials are not allowed under this specific program.

National Institutes Of Health

POSTED

about 1 month ago

DEADLINE

More opportunities from National Institutes Of Health → National Cancer Institute

Same awarding agency

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Solicitation # RFA-CA-28-004

The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.

Blood and Organ Banks

POSTED

DEADLINE

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

Solicitation # PAR-28-014

The National Cancer Institute, under the National Institutes of Health, is soliciting applications for solicitation PAR-28-014 to investigate the causes and biological mechanisms of sporadic non-hereditary early-onset cancers in adults aged 18 to 49. The primary goal of this initiative is to understand the rising incidence of these cancers to improve prevention and control strategies. Research should specifically target environmental or lifestyle drivers across various demographics, the biological host responses involved, or the development of more effective methods for identifying high-risk individuals. This funding opportunity supports both standard research projects and exploratory or developmental studies through a grant award instrument, with clinical trials being optional. Interested parties must submit their applications by the deadline of October 12, 2029.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in almost 3 years

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

Solicitation # PAR-28-022

The National Cancer Institute, potentially in collaboration with the National Institute of Dental and Craniofacial Research, is soliciting applications for P50 Research Center Grants for Specialized Programs of Research Excellence. This program supports investigator-initiated translational research focused on the prevention, early detection, diagnosis, and treatment of organ-specific cancers or closely related cancer groups. Eligible research must be grounded in human biology using genetic, molecular, biochemical, structural, or cellular experimental approaches and must achieve a translational human endpoint within the grant period. Under solicitation number PAR-28-022, this opportunity covers the years 2027, 2028, and 2029 and requires the inclusion of clinical trials. The notice was posted on October 14, 2026, with a final response deadline of September 26, 2029. This initiative serves as a re-issuance of PAR-23-284 to continue funding state-of-the-art research aimed at improving clinical outcomes for cancer patients.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in almost 3 years

Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

Solicitation # RFA-CA-28-013

The National Cancer Institute, under the National Institutes of Health, is seeking meritorious proposals for the Carcinogen Hazard Assessment Monographs Program (CHAMP) Initiative. This solicitation, identified as RFA-CA-28-013, aims to fund projects that critically and systematically evaluate scientific evidence regarding carcinogenic hazards to humans to better inform cancer research, control, and prevention efforts. Interested applicants must submit their proposals by the response deadline of February 10, 2027. This opportunity is categorized as an R01 grant, and it is explicitly noted that clinical trials are not allowed under this specific funding program.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Notice of Change in Application Due Date for RFA-CA-27-005 "Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)"

Solicitation # NOT-CA-26-020

This notice issued by the National Cancer Institute of the National Institutes of Health serves to amend the application timeline for the Glioblastoma Therapeutics Network clinical trial solicitation, RFA-CA-27-005. The primary modification is the addition of a second application due date on January 11, 2027, for new, renewal, resubmission, and revision applications. Under this new cycle, the scientific merit review is scheduled for June 2027, followed by an advisory council review in August 2027, with an earliest start date of December 2027. The expiration date for this specific window is January 12, 2027. All other terms and conditions of the original notice of funding opportunity remain unchanged.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)

Solicitation # PAR-28-057

The National Cancer Institute is soliciting applications under solicitation PAR-28-057 to establish the Management and Data Coordination Unit as a key scientific component of the Pancreatic Cancer Detection Consortium. This initiative focuses on the early detection of pancreatic ductal adenocarcinoma and the characterization of precursor lesions to identify high-risk patients, aligning with the NCI's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma. The selected unit will be responsible for providing critical infrastructure and collaborative support, including study design, protocol development, statistical analysis, and comprehensive data management. Additionally, the unit will oversee the coordination of biorepository building and provide the necessary organizational and logistics support to ensure the successful operation of the consortium. Applications must be submitted by the deadline of May 26, 2027.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

Solicitation # PAR-28-056

The National Cancer Institute is soliciting applications for Research Units as part of the Pancreatic Cancer Detection Consortium to advance the early detection of pancreatic ductal adenocarcinoma and the characterization of precursor lesions. These multi-disciplinary teams will focus on developing and testing molecular and imaging biomarkers to identify high-risk patients and those with lesions likely to progress to cancer. Key research activities include the use of machine learning for biomarker discovery, conducting validation studies, and collecting longitudinal biospecimens for a centralized biorepository. Under solicitation PAR-28-056, the selected Research Units are required to engage in collaborative efforts, sharing data and biospecimens across the consortium. The initiative aligns with the NCI's scientific framework for pancreatic cancer by prioritizing the identification of patients who could benefit from early intervention based on genetic factors, family history, or existing precursor lesions. Applications for this federal opportunity are due by November 6, 2029.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

in about 3 years

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS